Site-directed mutagenesis of the human dopamine D2 receptor
dc.contributor.author | Mansour, Alfred | en_US |
dc.contributor.author | Meng, Fan | en_US |
dc.contributor.author | Meador-Woodruff, James H. | en_US |
dc.contributor.author | Taylor, Larry P. | en_US |
dc.contributor.author | Civelli, Olivier | en_US |
dc.contributor.author | Akil, Huda | en_US |
dc.date.accessioned | 2006-04-10T15:03:07Z | |
dc.date.available | 2006-04-10T15:03:07Z | |
dc.date.issued | 1992-10-01 | en_US |
dc.identifier.citation | Mansour, Alfred, Meng, Fan, Meador-Woodruff, James H., Taylor, Larry P., Civelli, Olivier, Akil, Huda (1992/10/01)."Site-directed mutagenesis of the human dopamine D2 receptor." European Journal of Pharmacology: Molecular Pharmacology 227(2): 205-214. <http://hdl.handle.net/2027.42/29803> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B73F6-48065CD-3S/2/bc4f234f4fa8c7037ec1ee3eb1843784 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/29803 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=1358663&dopt=citation | en_US |
dc.description.abstract | Based on amino acid sequence and computer modeling, two conflicting three-dimensional models of the dopamine D2 receptor have been proposed. One model (Dahl et al., 1991, Proc. Natl. Acad. Sci. USA 88, 8111) suggests that dopamine interacts with aspartate 80 of transmembrane (TM) 2 and asparagine 390 of TM6 with the transmembranes arranged in a clockwise manner, while a second model (Hibert et al., 1991, Mol. Pharmacol. 40, 8) suggests that dopamine interacts with aspartate 114 of TM3 and the serines of TM5 (194 and 197) with the transmembranes arranged in a counterclockwise manner when viewed from the extracellular space. The present study tests the latter model by selectively mutating aspartate 114 and serines 194 and 197 of the human dopamine D2 receptor by site-directed mutagenesis. In addition, two methionines (116 and 117) were mutated to evaluate whether residues near aspartate (114) of the dopamine D2 receptor are critical in differentiating dopamine receptor agonists from adrenoceptor agonists. Removal of the negative charge with the mutation of aspartate (114) to either asparagine or glycine led to a total loss of both agonist and antagonist binding. Individual or dual methionine mutations in positions 116 and 117, to make the dopamine D2 binding pocket more closely resemble the [beta]2-adrenoceptor, did not result in a change in selectivity toward noradrenergic agonists or antagonists. The serine mutations revealed interesting differences between the dopamine D2 receptor and the adrenoceptors. In particular serine 197 appeared more important than serine 194 for agonist binding. In addition, the binding of one agonist (N-0437) was unaffected by individual serine mutations, while the binding of some antagonists, such as raclopride and spiperone, was significantly altered. These findings are discussed in relation to ligand structure and their interactions with the putative binding pocket. | en_US |
dc.format.extent | 944458 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Site-directed mutagenesis of the human dopamine D2 receptor | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Mental Health Researcg Institute, University of Michigan, Ann Arbor, MI 48109-0720, USA | en_US |
dc.contributor.affiliationum | Mental Health Researcg Institute, University of Michigan, Ann Arbor, MI 48109-0720, USA | en_US |
dc.contributor.affiliationum | Mental Health Researcg Institute, University of Michigan, Ann Arbor, MI 48109-0720, USA | en_US |
dc.contributor.affiliationum | Mental Health Researcg Institute, University of Michigan, Ann Arbor, MI 48109-0720, USA | en_US |
dc.contributor.affiliationum | Mental Health Researcg Institute, University of Michigan, Ann Arbor, MI 48109-0720, USA | en_US |
dc.contributor.affiliationother | Vollum Institute of Advanced Biological Research, Oregon Health Sciences University, Portland, OR 97201, USA | en_US |
dc.identifier.pmid | 1358663 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/29803/1/0000149.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0922-4106(92)90129-J | en_US |
dc.identifier.source | European Journal of Pharmacology: Molecular Pharmacology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.